Abstract. The pancreatic glucagon (IRG) 
healthy male subjects without a family history of diabetes, and in 24 male patients with endogenous hyperlipoproteinaemia, by means of a 2 h-glucose infusion (12 mg/kg/ min) primed by an initial injection of 0.33 g/kg. The hyperlipoproteinaemic group consisted of 8 non-obese subjects with normal carbohydrate tolerance (group A), 8 non-obese (group B) and 8 obese (group C) subjects with maturity onset type diabetes mellitus controlled diet alone.
Group B was characterized by a lack of IRI-response to glucose whereas a hyperinsulinaemia was found both in group A and C. The fasting IRG levels increased from controls (29.7 \m=+-\2.3 pmol/1) to group A (36.7 \m=+-\6.5 pmol/l; n.s.), group B 47.3 \m=+-\8.8 pmol/l; P < 0.05) and group C (57.7 \m=+-\8.2 pmol/l; P < 0.01). In group A the IRG concentration pattern was comparable with that of the controls. On the contrary, in groups B and C the IRG levels remained significantly higher inspite of the excessive hyperglycaemia achieved by the glucose infusion, suggesting a reduced suppressibility of the alpha cell function to glucose. In addition, the latter groups were characterized by a lack of an IRG rebound after termination of the glucose infusion. No correlation was found between hyperglycaemia and the degree of IRG rebound in all groups so far studied. A diminished molar I RI \ x=req-\ IRG-ratio was found in group B whereas an increase ratio was recorded in groups A and C during glucose infusion. There were no correlation between IRG secretion and relative body weight, carbohydrate tolerance or IRI-response to glucose. Our findings suggest a normal alpha cell response to glucose in hyperlipoproteinaemia without obesity and carbohydrate intolerance. The abnormal alpha cell function in non-obese and obese hyperlipoproteinaemics with maturity onset type diabetes mellitus is a feature characteristic of diabetes than of hyperlipoproteinaemia.
Numerous abnormalities of glucagon secretion have been described in both juvenile-onset and adult-onset diabetes mellitus (Gerich 1976; Unger et al. 1972; Unger 1974) . In addition, a basal and arginin-induced hyperglucagonaemia was ob¬ served in hyperlipoproteinaemic patients (Eaton 1973b; Tiengo et al. 1977) . Variations in insulin and glucagon concentrations and their molar ratio may play an important role in the pathogenesis of abnormal triglycéride metabolism by the liver (Eaton 1976 (Eaton 1977 ). An alteration in glucagon secretion or a decreased glucagon activity may be responsible for the development and/or mainte¬ nance of the hyperlipoproteinaemic states (Eaton etal. 1974 (Ziegler et al. 1971 ). Pancreatic glucagon (IRG) was measured by radioimmunoassay using specific antiserum R4 obtained from a rabbit by immunization with cross-linked glucagon (Ziegler et al. 1975 ). This antiserum R4 did not cross-react with por¬ cine gut-GLI in a physiological range. The glucagon standard used was a gift of the WHO International Laboratory for Biological Standards, London. The me¬ thod for pancreatic glucagon determination has already been described in detail (Fig. 1) and by the significantly greater AIRI-area 30-120 min (Table 1) . On the contrary, group B is character¬ ized by a significantly reduced early and late insulin secretion phase ( Fig. 1 and Table 1 ).
In groups B and C the IRG-levels in the fasting stage and during glucose infusion were signifi¬ cantly higher in comparison to controls (Fig. 2 and Table 2 ). In group A, however, the mean fasting IRG concentration was found to be slightly but not significantly higher whereas the IRG levels during glucose infusion were comparable with those of the controls (Fig. 2) .
The artificial hyperglycaemia was associated with a tendency to suppress the IRG levels during the first 60 min of the GIT in all groups ( (Fig. 3) reflects a lack of insulin response ( Fig. 1) and significantly increased IRG levels (Fig. 2) 
Discussion
When studying the glucagon and insulin secretion in this selected population of healthy controls and hyperlipoproteinaemics of 20 -40 years of age, the age difference between the groups studied should be taken into consideration. However, glucagon and insulin secretion of healthy subjects in the age range of 20-40 years are not appreciably altered with advancing age (Dudl & Ensinck 1977) . This is in agreement with our preliminiary findings con¬ cerning the basal and glucose stimulated insulin response during a glucose infusion test. For this reason, the age difference in the range of years between controls and hyperlipoproteinae¬ mics patients is of no importance with regard to the glucagon and insulin secretion in this selected population studied.
Insulin and glucagon have a direct and antago¬ nistic effect upon hepatic lipoprotein production. In fact, whereas glucagon decreases the triglycé¬ ride lipoprotein production in the perfused rat liver (Eaton 1973a; Tiengo et al. 1977) insulin has the opposite effect (Topping & Mayes 1971) . Eaton (1977) proposed the hypothesis that a reduction in net glucagon activity may be of signifi¬ cance for mediating or participating in the devel- (group B) were characterized by a lack of insulin response to glucose. In addition, the early insulin secretion phase was significantly re¬ duced in hyperlipoproteinaemic subjects with dia¬ betes mellitus independent of the body weight. This is consistent with findings in subjects with different degrees of carbohydrate intolerance with¬ out hyperlipoproteinaemia Schulzetal. 1978) .
Normally a rise in glucose concentration is ac¬ companied by a decline in plasma IRG levels, and a decline in glycaemia is associated with a rise in IRG (Unger & Orci 1977 (Tiengo et al. 1977 The molar IRI-IRG ratio plays an important role in the regulation of various hepatic functions such as the production of proteins, lipids and glucose (Eaton et al. 1974; Eaton 1977) . Variations in the relationship of insulin and glucagon levels are probably of significance in determination of the abnormal triglycéride production by the liver (Eaton 1977) . Both in normal weight non-diabetic and obese diabetic hyperlipoproteinaemics the mo¬ lar IRI-IRG ratio during glucose infusion was markedly increased reflecting a disturbed bihormonal regulation in these subjects. However, the ratio was found to be diminished in non-obese diabetic hyperlipoproteinaemics. This is in agree¬ ment with findings in maturity onset type diabetics without hyperlipoproteinaemia .
In accordance with findings in non-hyperlipoproteinaemic subjects with different degrees of carbohydrate intolerance (Schulz et 
